文献速递免疫规划

额外早期麻疹疫苗剂量对儿童住院或死亡无影响:一项随机对照试验

No effect of an additional early dose of measles vaccine on hospitalization or mortality in children: A randomized controlled trial.
PubMed 文献 · Vaccine · 2018-03-06

在布基纳法索Nouna HDSS的随机对照试验中,2258名干预组儿童在含DTP五联疫苗第三剂后4周接种额外早期麻疹疫苗,2238名对照组儿童仅9月龄接种标准麻疹疫苗。干预组与对照组住院或死亡复合终点无差异(HR=1.00,95%CI 0.83-1.20),未检出早期麻疹疫苗对后续住院或死亡的影响。

要点

  • 额外早期麻疹疫苗未降低4.5-36月龄儿童住院或死亡复合终点风险(HR=1.00,95%CI 0.83-1.20)。
  • 符合方案分析与意向性分析结果相似。
  • 结果提示早期麻疹疫苗可能对入组后未接触口服脊髓灰质炎疫苗活动的儿童有益,但未达统计学显著(HR=0.83,95%CI 0.55-1.29)。

核心结论

  • 未检出额外早期麻疹疫苗对后续住院或死亡的影响。
  • 早期麻疹疫苗的可能效应可能被频繁口服脊髓灰质炎疫苗活动的非特异性效应所掩盖。

研究设计与样本

  • 随机对照试验,分析次要结局。
  • 儿童随机分为对照组(9月龄接种标准麻疹疫苗)或干预组(含DTP五联疫苗第三剂后4周接种额外早期麻疹疫苗,并于9月龄接种标准麻疹疫苗)。
  • 在布基纳法索Nouna HDSS纳入4.5至36月龄儿童,干预组2258名,对照组2238名。
  • 采用Cox比例风险回归分析重复事件,以入组时间为时间尺度。
  • 试验注册于ClinicalTrials.gov,NCT01644721。

主要发现

  • 共观察到464次住院或死亡事件。
  • 干预组与对照组住院或死亡复合终点无差异(HR=1.00,95%CI 0.83-1.20)。
  • 符合方案分析与意向性分析结果相似。
  • 入组后未接触口服脊髓灰质炎疫苗活动的儿童中,早期麻疹疫苗可能有益但未达统计学显著(HR=0.83,95%CI 0.55-1.29)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 早期麻疹疫苗的可能效应可能被频繁口服脊髓灰质炎疫苗活动的非特异性效应所掩盖。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Non-specific effects (NSEs) of vaccines have increasingly gained attention in recent years. Recent studies suggest that live vaccines, such as measles vaccine (MV), have beneficial effects on health, while inactivated vaccines, such as the diphtheria-tetanus-pertussis (DTP) vaccine, may have harmful effects. If this is the case, it should improve child health to move MV closer to the last vaccination with DTP. The objective of this study was to investigate the NSEs of an additional early dose of MV on hospitalization or mortality. METHODS: Children were randomized to receive either the standard MV at 9 months (control) or an additional early dose of MV 4 weeks after the third dose of DTP-containing Pentavalent vaccine and the standard MV at 9 months (intervention). In this analysis of a secondary outcome in the trial, we investigated the effect of the intervention on a composite endpoint of over-night hospitalization with or without recovery, or death without previous hospitalization, in children between 4.5 and 36 months of age in the Nouna HDSS in Burkina Faso. We used Cox proportional hazards regression with repeated events and time since study enrolment as underlying time-scale. RESULTS: Among 2258 children in the intervention and 2238 children in the control group we observed a total of 464 episodes of hospitalization or mortality. There was no difference between intervention and control group (HR = 1.00, 95% Confidence Interval (CI) 0.83-1.20). Results from the per-protocol and intention-to-treat analysis were similar. Although no significant, results suggest a possible beneficial effect of early MV in children that had not been exposed to an OPV campaign after enrolment (HR = 0.83, 95% CI 0.55-1.29). CONCLUSIONS: We did not detect any effect of early MV on subsequent hospitalization or mortality. However, possible effects of early MV could have been obscured by NSEs of the frequent OPV campaigns. Registration: The trial was registered at ClinicalTrials.gov, NCT01644721.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Schoeps A, Nebié E, Fisker AB, et al. No effect of an additional early dose of measles vaccine on hospitalization or mortality in children: A randomized controlled trial. Vaccine. 2018. PMID: 29523450. doi:10.1016/j.vaccine.2018.02.104

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。